Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAj1OdBZEz32H3hM13nGcYskdUTZavqhGSQT_EBPMcUQk#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label "Maprotiline hydrochloride tablets are contraindicated in patients hypersensitive to maprotiline and in patients with known or suspected seizure disorders. It should not be given concomitantly with monoamine oxidase (MAO) inhibitors. A minimum of 14 days should be allowed to elapse after discontinuation of MAO inhibitors before treatment with maprotiline is initiated. Effects should be monitored with gradual increase in dosage until optimum response is achieved. The drug is not recommended for use during the acute phase of myocardial infarction." assertion.
- association object DOID_5844 assertion.
- association predicate treats assertion.
- DOID_5844 category Disease assertion.
- drugbank:DB00934 category Drug assertion.
- association subject drugbank:DB00934 assertion.
- association provided_by NeuroDKG assertion.
- association relation MedicalContraindication assertion.